MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
244K 157K 56K
Gross Profit
-244K -157K -56K
Operating Income
-68.19M -35.31M -25.16M
Interest Income
6.27M 2.75M 372K
Pretax Income
-61.92M -32.56M -26.14M
Net Income
-61.92M -32.56M -26.14M
Selling & General & Admin
10.78M 6.78M 3.76M
Research & Development
57.41M 28.53M 21.4M
Other Expenses
n/a n/a n/a
Operating Expenses
68.19M 35.31M 25.16M
Interest Expense
n/a n/a 374K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
68.19M 35.31M 25.16M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
33.39M 31.85M 31.85M
Shares Outstanding (Diluted)
33.39M 31.85M 31.85M
EPS (Basic)
-1.85 -1.02 -0.82
EPS (Diluted)
-1.85 -1.02 -0.82
EBITDA
-67.95M -35.15M -25.7M
EBIT
-68.19M -35.31M -25.76M
Depreciation & Amortization
244K 157K 56K